Pre-earnings options volume in Travere Therapeutics (TVTX) is normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 5.7%, or $2.56, after results are released. Median move over the past eight quarters is 2.8%.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TVTX:
- Travere Therapeutics, Inc. (TVTX) Q1 Earnings Cheat Sheet
- Travere Therapeutics price target raised to $56 from $54 at Guggenheim
- Travere’s Sparsentan Trial Delivers Mixed but Defining Results in Rare Kidney Disease
- Travere Therapeutics price target raised to $43 from $31 at Stifel
- Morning News Wrap-Up 4/14/26: Today’s Biggest Stock Market Stories!